Matrix Contraction by Dermal Fibroblasts Requires Transforming Growth Factor-β/Activin-Linked Kinase 5, Heparan Sulfate-Containing Proteoglycans, and MEK/ERK
- 1 December 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 167 (6), 1699-1711
- https://doi.org/10.1016/s0002-9440(10)61252-7
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- An increased transforming growth factor β receptor type I:Type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase‐deficient transforming growth factor β receptor type II in sclerodermaArthritis & Rheumatism, 2004
- Insights Into the Molecular Mechanism of Chronic Fibrosis: The Role of Connective Tissue Growth Factor in SclerodermaJournal of Investigative Dermatology, 2004
- Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblastsArthritis & Rheumatism, 2003
- Prostacyclin derivatives prevent the fibrotic response to TGFβ2 by inhibiting the Ras/MEK/ERK pathwayThe FASEB Journal, 2002
- Dysregulation of transforming growth factor β signaling in scleroderma: Overexpression of endoglin in cutaneous scleroderma fibroblastsArthritis & Rheumatism, 2002
- Myofibroblasts and mechano-regulation of connective tissue remodellingNature Reviews Molecular Cell Biology, 2002
- Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4JCI Insight, 2001
- Expression of TGF-β1, -β2 and -β3 in localized and systemic sclerodermaJournal of Dermatological Science, 1999
- Syndecans-1 and -4 Are Induced During Wound Repair of Neonatal but Not Fetal SkinJournal of Investigative Dermatology, 1996
- Elevated proα2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding geneFEBS Letters, 1987